Risk of leukemia associated with the first course of cancer treatment: an analysis of the surveillance, epidemiology, and end results program experience = Risque de leucémie associé au premier cycle de traitement des cancers. Analyse de la surveillance, épidémiologie et résultats finals d'un programme d'expérienceCURTIS, R. E; HANKEY, B. F; MYERS, M. H et al.Journal of the National Cancer Institute. 1984, Vol 72, Num 3, pp 531-544, issn 0027-8874Article

Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trialMOREAU, Philippe; ATTAL, Michel; KETTERER, Nicolas et al.Blood. 2011, Vol 117, Num 11, pp 3041-3044, issn 0006-4971, 4 p.Article

Résumés/1er. Congrès international sur la chimiothérapie néoadjuvante, Paris, France, 6-9 novembre 1985 = Abstracts/First international congress on neo-adjuvant chemotherapy, Paris, France, 6-9 november 1985JACQUILLAT, C; WEIL, M; KHAYAT, D et al.Cancer drug delivery. 1986, Vol 3, Num 1, pp 45-91, issn 0732-9482Conference Proceedings

Les infections à herpès virus au cours du traitement d'induction de la rémission des leucémies aiguës = Herpes virus infections during remission induction chemotherapy for acute leukemiasMARTY, M; PONTUS, C; SCIEUX, C et al.La Semaine des hôpitaux de Paris. 1983, Vol 59, Num 39, pp 2687-2691, issn 0037-1777Article

Microwave tumour coagulation plus in situ treatment with cytokine-microparticles : Induction of potent anti-residual tumour immunityKUANG, M; LIU, S. Q; SAIJO, K et al.International journal of hyperthermia. 2005, Vol 21, Num 3, pp 247-257, issn 0265-6736, 11 p.Article

Leucémie aiguë promyélocytaire: étude rétrospective de 119 malades traités par Daunorubicine = Acute promyelocytic leukemia: a retrospective study of 119 patients with DNR containing regimensMARTY, M; GANEM, G; FISCHER, J et al.Nouvelle revue française d'hématologie. 1984, Vol 26, Num 6, pp 371-378, issn 0029-4810Article

Controversies About Induction TherapyIPPOLITI, G; PELLEGRINI, C; NIESWANDT, V et al.Transplantation proceedings. 2011, Vol 43, Num 6, pp 2450-2452, issn 0041-1345, 3 p.Conference Paper

Conservation of first-line antiretroviral treatment regimen where therapeutic options are limitedORRELL, Catherine; HARLING, Guy; LAWN, Stephen D et al.Antiviral therapy (London). 2007, Vol 12, Num 1, pp 83-88, issn 1359-6535, 6 p.Article

Neo-adjuvant chemotherapy : proceedings of the first international congress, Paris, 6-9 November 1985 = Chimiothérapie néo-adjuvanteKhayat, David; Weil, Marise; Jacquillat, Claude et al.Colloques INSERM. 1986, issn 0768-3154, isbn 0-86196-077-7, XXX-863 p, isbn 0-86196-077-7Conference Proceedings

NOUVELLE POLYCHIMIOTHERAPIE DE LA LEUCEMIE AIGUE MYELOIDE.FIERE D; BRYON PA; MARTIN C et al.1975; NOUV. PRESSE MED.; FR.; DA. 1975; VOL. 4; NO 29; PP. 2114Article

ON THE MODE OF DECREASE OF LEUKEMIC CELLS DURING TREATMENT OF ACUTE LEUKEMIAMASAOKA T; HASEGAWA Y; UEDA T et al.1976; EUROP. J. CANCER; G.B.; DA. 1976; VOL. 12; NO 2; PP. 143-149; BIBL. 4 REF.Article

MANAGEMENT OF ACUTE LEUKEMIA IN ADULTS.ELLISON RR.1975; MED. PEDIATR. ONCOL.; U.S.A.; DA. 1975; VOL. 1; NO 2; PP. 149-158; BIBL. 2 P.Article

NON-HODGKIN'S LYMPHOMA IN CHILDREN.BURCHENAL JH; LIEBERMAN PH; EXELBY PR et al.1975; MED. PEDIATR. ONCOL.; U.S.A.; DA. 1975; VOL. 1; NO 3; PP. 235-263; BIBL. 3 P.Article

DIE THERAPIE DER AKUTEN MYELOISCHEN LEUKAEMIE. = LA THERAPEUTIQUE DE LA LEUCEMIE MYELOIDE AIGUESAUTER C.1975; SCHWEIZ. NED. WSCHR.; SCHWEIZ.; DA. 1975; VOL. 105; NO 40; PP. 1281-1286; ABS. ANGL.; BIBL. 11 REF.; (41. FORTBILDUNGSKURS SCHWEIZ. GES. INN. MED.; SOLOTHURN; 1975)Conference Paper

EVOLUTION DE 229 LEUCEMIES MYELOIDES AIGUES. TRAITEMENTS D'INDUCTION VARIABLESFIERE D; BRYON PA; MARTIN C et al.1976; LYON MED.; FR.; DA. 1976; VOL. 235; NO 6; PP. 479-483; ABS. ANGL.; BIBL. 7 REF.Article

Pituitary apoplexy during induction chemotherapy for acute myeloid leukaemiaSILBERSTEIN, L; JOHNSTON, C; BHAGAT, A et al.British journal of haematology. 2008, Vol 143, Num 2, pp 151-151, issn 0007-1048, 1 p.Article

The Use of Different Induction and Maintenance Chemotherapy Regimens for the Treatment of Advanced Yolk Sac Tumors. CommentaryGREEN, Daniel M; BRECHER, Martin L; GROSSI, Mauro et al.GREEN, Daniel M; Journal of clinical oncology. 2008, Vol 26, Num 20, issn 0732-183X, c159-c164, 3297-3298 [8 p.]Article

Surgical resection for residual N₂ disease after induction chemotherapyPORT, Jeffrey L; KORST, Robert J; LEE, Paul C et al.The Annals of thoracic surgery. 2005, Vol 79, Num 5, pp 1686-1690, issn 0003-4975, 5 p.Article

Comment se pose aujourd'hui la question du sevrage : les traitements de substitution doivent-ils constituer les traitements de première intention dans la dépendance aux opiacés ? = What are the objectives and expected results of opioid replacement therapy ? What is the current situation of withdrawal: Should replacement therapies constitute first-line treatments in opioid dependency?VALLEUR, Marc.Alcoologie et addictologie. 2004, Vol 26, Num 4, pp 27S-33S, issn 1620-4522, SUPConference Paper

Induction chemotherapy for organ preservation in advanced laryngeal cancer: is there a role?WOLF, G. T; WAUN KI HONG.Head & neck. 1995, Vol 17, Num 4, pp 279-283, issn 1043-3074Conference Paper

Review: advances in the therapy of acute nonlymphocytic leukemiaSTEIN, R. S.The American journal of the medical sciences. 1989, Vol 297, Num 1, pp 26-34, issn 0002-9629Article

Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemiaAMATO, R; KANTARJIAN, H; WALTERS, R et al.Cancer. 1988, Vol 61, Num 4, pp 650-653, issn 0008-543XArticle

Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemiaRAUTONEN, J; HOVI, L; SIIMES, M. A et al.Blood. 1988, Vol 71, Num 4, pp 989-991, issn 0006-4971Article

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adultsHOELZER, D; THIEL, E; MASCHMEYER, G et al.Blood. 1988, Vol 71, Num 1, pp 123-131, issn 0006-4971Article

How should acute lymphoblastic leukaemia relapsing after bone-marrow transplantation be treated?BARRETT, A. J; JOSHI, R; JEW, C et al.Lancet (British edition). 1985, Vol 1, Num 8439, pp 1189-1191, issn 0140-6736Article